Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

The age of genomic profiling

BGICC 2020

Published: 27 Jan 2020

Views: 1437

Rating:

Save

Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey

Prof Cengiz Yakicier spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about advances in genomic technologies.

He outlines the importance and use of genomic profiling, and also how a decrease in cost is leading to more accessible personalised medicine.

Related Videos

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA

Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria...

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic...

Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City...

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer ( Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA )

Breast and emerging indications for IORT

Dr David Martinez Perez - AUNA, Lima, Peru

Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru

The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )

The pros and cons of breast IORT and ultra hypofractionation (FR)

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France

$The pros and cons of breast IORT and ultra hypofractionation (FR) ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )$

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

Global adoption of single-shot targeted IORT for breast cancer

Dr Jayant Vaidya - University College London, London, UK

Global adoption of single-shot targeted IORT for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )

The advancements in radiotherapy for breast cancer patients

Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia

The advancements in radiotherapy for breast cancer patients ( Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia )

More from ecancer